In a surprising turn of events, the Australian stock market has faced a minor decline, with the ASX200 sliding by 0.35%. This dip comes as trading volumes wane, influenced by Thanksgiving holidays in the United States. Despite the market downturn, smaller companies

Asian markets presented a varied picture on Friday, amid a day of mixed trading post-Thanksgiving with U.S. markets temporarily paused before resuming for a short session. However, U.S. futures and energy prices trended upwards. In Japan, Tokyo’s Nikkei 225 index experienced a

A groundbreaking Australian biotech is gearing up for a significant ASX debut, aiming for a transformative impact on cancer treatment. HaemaLogiX, a cutting-edge biotech firm with a stellar list of investors, is preparing for a major milestone—an initial public offering (IPO) on

In today’s volatile global market, tech stocks are making substantial waves, particularly smaller-cap companies outshining larger ones. This remarkable trend is propelled by encouraging labor statistics and optimism surrounding cutting-edge innovations like artificial intelligence and increased clean energy demands. As a result,